Loading…

Inflammatory pathophysiological mechanisms implicated in postpartum depression

Postpartum Depression (PPD) is a serious psychiatric disorder of women within the first year after delivery. It grievously damages women’s physical and mental health. Inflammatory reaction theory is well-established in depression, and also has been reported associated with PPD. This review summarize...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2022-11, Vol.13, p.955672-955672
Main Authors: Zhu, Jialei, Jin, Jing, Tang, Jing
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c442t-50e06104aad3379c2a3dd78bd6748b58a3fce9b7a3e1c58d98cd7f3ad05b886f3
cites cdi_FETCH-LOGICAL-c442t-50e06104aad3379c2a3dd78bd6748b58a3fce9b7a3e1c58d98cd7f3ad05b886f3
container_end_page 955672
container_issue
container_start_page 955672
container_title Frontiers in pharmacology
container_volume 13
creator Zhu, Jialei
Jin, Jing
Tang, Jing
description Postpartum Depression (PPD) is a serious psychiatric disorder of women within the first year after delivery. It grievously damages women’s physical and mental health. Inflammatory reaction theory is well-established in depression, and also has been reported associated with PPD. This review summarized the inflammatory pathophysiological mechanisms implicated in PPD, including decreased T cell activation, increased proinflammatory cytokines secretion, active kynurenine pathway, and initiated NLRP3 inflammasome. Clinical and preclinical research are both gathered. Potential therapeutical alternatives targeting the inflammatory mechanisms of PPD were introduced. In addition, this review briefly discussed the differences of inflammatory mechanisms between PPD and depression. The research of inflammation in PPD is limited and seems just embarking, which indicates the direction we can further study. As a variety of risky factors contribute to PPD collectively, therapy for women with PPD should be comprehensive, and clinical heterogeneity should be taken into consideration. As PPD has a predictability, early clinical screening and interventions are also needed. This review aims to help readers better understand the inflammatory pathological mechanisms in PPD, so as to identify biomarkers and potential therapeutic targets in the future.
doi_str_mv 10.3389/fphar.2022.955672
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_33cd1d58b0794e4ca4b883319d3f47da</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_33cd1d58b0794e4ca4b883319d3f47da</doaj_id><sourcerecordid>2738495310</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-50e06104aad3379c2a3dd78bd6748b58a3fce9b7a3e1c58d98cd7f3ad05b886f3</originalsourceid><addsrcrecordid>eNpVkU1rHDEMhoeSQkOaH9DbHHvZjT3y-ONSCCFNFkJ7ac9GY3t2HOyxY88G9t9nkg2l0UXilfRI8DbNN0q2AFJdjXnCsu1I121V33PRfWrOKeewUZJ2Z__VX5rLWh_JGqAUcHbe_NrNY8AYcUnl2GZcppSnY_UppL03GNrozISzr7G2PuawaouzrZ_bnOqSsSyH2FqXi6vr0vy1-TxiqO7yPV80f3_e_rm53zz8vtvdXD9sDGPdsumJI5wShmgBhDIdgrVCDpYLJodeIozGqUEgOGp6aZU0VoyAlvSDlHyEi2Z34tqEjzoXH7EcdUKv34RU9np9zZvgNICx1PZyIEIxxwyyFQFAlYWRCYsr68eJlQ9DdNa4eSkYPkA_dmY_6X161opzJZhaAd_fASU9HVxddPTVuBBwdulQdSdAMtUDJesoPY2akmotbvx3hhL96qV-81K_eqlPXsILgWSWvw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2738495310</pqid></control><display><type>article</type><title>Inflammatory pathophysiological mechanisms implicated in postpartum depression</title><source>PubMed Central</source><creator>Zhu, Jialei ; Jin, Jing ; Tang, Jing</creator><creatorcontrib>Zhu, Jialei ; Jin, Jing ; Tang, Jing</creatorcontrib><description>Postpartum Depression (PPD) is a serious psychiatric disorder of women within the first year after delivery. It grievously damages women’s physical and mental health. Inflammatory reaction theory is well-established in depression, and also has been reported associated with PPD. This review summarized the inflammatory pathophysiological mechanisms implicated in PPD, including decreased T cell activation, increased proinflammatory cytokines secretion, active kynurenine pathway, and initiated NLRP3 inflammasome. Clinical and preclinical research are both gathered. Potential therapeutical alternatives targeting the inflammatory mechanisms of PPD were introduced. In addition, this review briefly discussed the differences of inflammatory mechanisms between PPD and depression. The research of inflammation in PPD is limited and seems just embarking, which indicates the direction we can further study. As a variety of risky factors contribute to PPD collectively, therapy for women with PPD should be comprehensive, and clinical heterogeneity should be taken into consideration. As PPD has a predictability, early clinical screening and interventions are also needed. This review aims to help readers better understand the inflammatory pathological mechanisms in PPD, so as to identify biomarkers and potential therapeutic targets in the future.</description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2022.955672</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>cytokine ; inflammasome ; inflammation ; kynurenine ; Pharmacology ; postpartum depression ; T cell</subject><ispartof>Frontiers in pharmacology, 2022-11, Vol.13, p.955672-955672</ispartof><rights>Copyright © 2022 Zhu, Jin and Tang. 2022 Zhu, Jin and Tang</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-50e06104aad3379c2a3dd78bd6748b58a3fce9b7a3e1c58d98cd7f3ad05b886f3</citedby><cites>FETCH-LOGICAL-c442t-50e06104aad3379c2a3dd78bd6748b58a3fce9b7a3e1c58d98cd7f3ad05b886f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669749/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669749/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Zhu, Jialei</creatorcontrib><creatorcontrib>Jin, Jing</creatorcontrib><creatorcontrib>Tang, Jing</creatorcontrib><title>Inflammatory pathophysiological mechanisms implicated in postpartum depression</title><title>Frontiers in pharmacology</title><description>Postpartum Depression (PPD) is a serious psychiatric disorder of women within the first year after delivery. It grievously damages women’s physical and mental health. Inflammatory reaction theory is well-established in depression, and also has been reported associated with PPD. This review summarized the inflammatory pathophysiological mechanisms implicated in PPD, including decreased T cell activation, increased proinflammatory cytokines secretion, active kynurenine pathway, and initiated NLRP3 inflammasome. Clinical and preclinical research are both gathered. Potential therapeutical alternatives targeting the inflammatory mechanisms of PPD were introduced. In addition, this review briefly discussed the differences of inflammatory mechanisms between PPD and depression. The research of inflammation in PPD is limited and seems just embarking, which indicates the direction we can further study. As a variety of risky factors contribute to PPD collectively, therapy for women with PPD should be comprehensive, and clinical heterogeneity should be taken into consideration. As PPD has a predictability, early clinical screening and interventions are also needed. This review aims to help readers better understand the inflammatory pathological mechanisms in PPD, so as to identify biomarkers and potential therapeutic targets in the future.</description><subject>cytokine</subject><subject>inflammasome</subject><subject>inflammation</subject><subject>kynurenine</subject><subject>Pharmacology</subject><subject>postpartum depression</subject><subject>T cell</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1rHDEMhoeSQkOaH9DbHHvZjT3y-ONSCCFNFkJ7ac9GY3t2HOyxY88G9t9nkg2l0UXilfRI8DbNN0q2AFJdjXnCsu1I121V33PRfWrOKeewUZJ2Z__VX5rLWh_JGqAUcHbe_NrNY8AYcUnl2GZcppSnY_UppL03GNrozISzr7G2PuawaouzrZ_bnOqSsSyH2FqXi6vr0vy1-TxiqO7yPV80f3_e_rm53zz8vtvdXD9sDGPdsumJI5wShmgBhDIdgrVCDpYLJodeIozGqUEgOGp6aZU0VoyAlvSDlHyEi2Z34tqEjzoXH7EcdUKv34RU9np9zZvgNICx1PZyIEIxxwyyFQFAlYWRCYsr68eJlQ9DdNa4eSkYPkA_dmY_6X161opzJZhaAd_fASU9HVxddPTVuBBwdulQdSdAMtUDJesoPY2akmotbvx3hhL96qV-81K_eqlPXsILgWSWvw</recordid><startdate>20221103</startdate><enddate>20221103</enddate><creator>Zhu, Jialei</creator><creator>Jin, Jing</creator><creator>Tang, Jing</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20221103</creationdate><title>Inflammatory pathophysiological mechanisms implicated in postpartum depression</title><author>Zhu, Jialei ; Jin, Jing ; Tang, Jing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-50e06104aad3379c2a3dd78bd6748b58a3fce9b7a3e1c58d98cd7f3ad05b886f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>cytokine</topic><topic>inflammasome</topic><topic>inflammation</topic><topic>kynurenine</topic><topic>Pharmacology</topic><topic>postpartum depression</topic><topic>T cell</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhu, Jialei</creatorcontrib><creatorcontrib>Jin, Jing</creatorcontrib><creatorcontrib>Tang, Jing</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhu, Jialei</au><au>Jin, Jing</au><au>Tang, Jing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inflammatory pathophysiological mechanisms implicated in postpartum depression</atitle><jtitle>Frontiers in pharmacology</jtitle><date>2022-11-03</date><risdate>2022</risdate><volume>13</volume><spage>955672</spage><epage>955672</epage><pages>955672-955672</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract>Postpartum Depression (PPD) is a serious psychiatric disorder of women within the first year after delivery. It grievously damages women’s physical and mental health. Inflammatory reaction theory is well-established in depression, and also has been reported associated with PPD. This review summarized the inflammatory pathophysiological mechanisms implicated in PPD, including decreased T cell activation, increased proinflammatory cytokines secretion, active kynurenine pathway, and initiated NLRP3 inflammasome. Clinical and preclinical research are both gathered. Potential therapeutical alternatives targeting the inflammatory mechanisms of PPD were introduced. In addition, this review briefly discussed the differences of inflammatory mechanisms between PPD and depression. The research of inflammation in PPD is limited and seems just embarking, which indicates the direction we can further study. As a variety of risky factors contribute to PPD collectively, therapy for women with PPD should be comprehensive, and clinical heterogeneity should be taken into consideration. As PPD has a predictability, early clinical screening and interventions are also needed. This review aims to help readers better understand the inflammatory pathological mechanisms in PPD, so as to identify biomarkers and potential therapeutic targets in the future.</abstract><pub>Frontiers Media S.A</pub><doi>10.3389/fphar.2022.955672</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2022-11, Vol.13, p.955672-955672
issn 1663-9812
1663-9812
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_33cd1d58b0794e4ca4b883319d3f47da
source PubMed Central
subjects cytokine
inflammasome
inflammation
kynurenine
Pharmacology
postpartum depression
T cell
title Inflammatory pathophysiological mechanisms implicated in postpartum depression
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A00%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inflammatory%20pathophysiological%20mechanisms%20implicated%20in%20postpartum%20depression&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Zhu,%20Jialei&rft.date=2022-11-03&rft.volume=13&rft.spage=955672&rft.epage=955672&rft.pages=955672-955672&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2022.955672&rft_dat=%3Cproquest_doaj_%3E2738495310%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-50e06104aad3379c2a3dd78bd6748b58a3fce9b7a3e1c58d98cd7f3ad05b886f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2738495310&rft_id=info:pmid/&rfr_iscdi=true